L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Presse Medicale

Volumn 42, Issue 4 PART2, 2013, Pages 507-510

  Cordier, Jean François ^a   Cottin, Vincent ^a   Guillevin, Loïc ^b   Bel, Elisabeth ^c   Bottero, Paolo ^d   Dalhoff, Klaus ^e   Humbert, Marc ^f   Lazor, Romain ^a,g   Sinico, Renato A ^h   Sivasothy, Pasupathy ⁱ   Wechsler, Michael E ^j  

^a LOUIS PRADEL HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Ospedale G Fornaroli   (Italy)

^e UNIVERSITY OF LÜBECK   (Germany)

^f BICÊTRE HOSPITAL   (France)

^g Service d'Angiologie Hôpital Universitaire   (Switzerland)

^h SAN CARLO BORROMEO HOSPITAL   (Italy)

ⁱ PAPWORTH HOSPITAL   (United Kingdom)

^j DEPARTMENT OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB;

CARDIOMYOPATHY; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; EOSINOPHIL COUNT; EOSINOPHILIC GRANULOMA; GASTROINTESTINAL DISEASE; GLOMERULONEPHRITIS; HEART DISEASE; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; LETTER; LUNG DISEASE; MAINTENANCE THERAPY; MEDICAL HISTORY; MYOCARDITIS; NOMENCLATURE; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; REMISSION; RISK FACTOR; SKIN MANIFESTATION;

EID: 84875611305     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.02.308     Document Type: Letter

References (16)

1. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
2. Kussmaul A., Maier R. Ueber eine bisher nicht beschriebene eigenthumliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmun einhergeht. Deutsches Arch Klin Med 1866, 1:484-518.
3. Hirsch J.G., Hirsch B.I. Paul Ehrlich and the discovery of the eosinophil. The eosinophil in health and disease 1980, 3-23. Grune and Stratton, New York. A.A.F. Mahmoud, K.F. Austen (Eds.).
4. Lamb A.R. Periarteritis nodosa - a clinical and pathological review of the disease. With a report of two cases. Arch Intern Med 1914, 14:481-516.
5. Churg J., Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951, 27:277-301.
6. Lanham J.G., Elkon K., Pusey C., Hughes G. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984, 63:65-81.
7. Masi A.T., Hunder G.G., Lie J.T., Michel B.A., Bloch D.A., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33:1094-1100.
8. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
9. Sinico R.A., Di Toma L., Maggiore U., Bottero P., Radice A., Tosoni C., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005, 52:2926-2935.
10. Sable-Fourtassou R., Cohen P., Mahr A., Pagnoux C., Mouthon L., Jayne D., et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005, 143:632-638.
11. Moosig F., Bremer J.P., Hellmich B., Holle J.U., Holl-Ulrich K., Laudien M., et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 2012, 10.1136/annrheumdis-2012-201531.
12. Healy B., Bibby S., Steele R., Weatherall M., Nelson H., Beasley R. Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome. J Allergy Clin Immunol 2013, 131(2):571-576.
13. Sinico R.A., Maggiore U., Tosoni C., Bottero P., Sabadini E., Giammarresi G., et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 2006, 47:770-779.
14. Keogh K.A., Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003, 115:284-290.
15. Comarmond C., Pagnoux C., Khellaf M., Cordier J.F., Hamidou M., Viallard J.F., et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study cohort. Arthritis Rheum 2013, 65:270-281.
16. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78:26-37.